ũ
Ż
3.5kg, 11 ȭ ũ ݸ ϰ
Ͽ. Ż goosehonking sound Բ . ð 11̰ ݸ ð 5~6ð̾. ݸ 6ð Ŀ Ͽ.
ݸ 87% 60g Ͽ methylxanthine alkaloids 276.66mg(, 79mg/kg) Ǿ. ġ緮 100~200mg/kg ġ緮 ġ Ͽ.
˻
ü˻
ü˻翡 Ǻ 嵵 ̾ CRT 1.5ʷ Ż ʾ,
5% Ż . ü 39, ɹڼ д 150ȸ, ȣ
Ÿ´. ȣ ణ ģ ̾, 鸮 ʾ, Ư ̻
ߵ ʾҴ.
ӻ ˻
װ˻翡 ALT 1.8 Ͽ, T.bil 0.8mg/dl ̾ϰ µǾ ־,
Glucose 175mg/dl 1.2 Ͽ. TP 8.1g/dl ణ µǾ ־, albumin 3.7g/dl ־, ֻġ(upper limit) . Ca 8.8mg/dl, P1.7mg/dl ҵǾ־. ̾, WBC 8.84K/ul , PCV 65.3% Ͽ Ż ǽɵǾ, ־.
Ǿ, ̷ ġ ȭ ǾǷ û ˻Ͽ
̻ ȮϿ, ˻ Ұ Ǿ.
缱 ˻
缱 ˻翡 ־ δ â ¿. 缱
˻翡 Ż Ǿ.
˻
ɹڼ 150~170 bpm̾, QRS ణ Ÿ sinus rhythm̾.
ݷ ȭ Ư ʾҴ(3).
3. ˻ . QRS ణ Ÿ.
˻
FS 53% Ǿ ־, HCM ɼ . MVI Ұ ʾҴ( 4).
ݸ ߵ
Ż
뼺 ɱٺ
ġ
ٷ ݸ ٷ Ͽ H2O2(3%) 5ml/kg 汸Ͽ 並 Ͽ
gastric lavage ǽϿ. ̹ methylxanthine alkaloid ϰ osmotic
cathartic ȿ ؼ Ȱź(activated charcoal) 2g/kg 6ð Ϸ絿 Ͽ.
- Fluid therapy: Ż methylxanthine alkaloids ȿ Ÿ Ͽ 0.9% saline
50ml/hr 4ð 뷮 1.5跮 Ͽ.
- Һ methylxanthine alkaloids ȿ Ͽ urine acidfier ascorbic acid 100mg/
kg bid óġϿ.
- methylxanthine alkaloids ǹǷ hepatic injury ϸ, ̿ hepatic protectant
óϿ. Taurine 5 ml(sid, IV), clanobutin 15mg/kg(sid, IV) óġϿ.
ġ緮 ʾǷ ġ ̶ Ͽ. ,
, ǥ ʾ. 翡 ջ Ͽ
ɺȣ ؾ ̴.
ݸ(methylxanthine alkaloid) , Ű, ߵ
Ÿ. Methylxanthin alkaloid ι(theobromine) ī(caffeine) ǥ̸, adenosine receptor Ͽ , , CNS ڱ Ѵ.
, ɱټ, CNS ڱذ Ѵ. ӻ 縦 Ÿµ,
ݸ 2~4ð Ŀ Ÿ. а , Ÿ , ɱ Ÿ. ַ ߰ Ѵ.ü˻ Ȯ ִ.
- hyperthermia
- hyperflexia
- tachycardia
- tachypnea
- hypotension
- Cardiac failure, weakness, comma, death
- Death: 12-36 hr after ingestion
īΰ ι ġ緮 100~200mg/kg, , baking ݷ 0.7g/kg, ڿ 60 g/
kg ִ. óġ óġ Ʈ, ٿְ,䰡 Ͻ ĽŰ ̴.
Ķ 並 ϱ H2O2 1~5ml/kg ̰, 䰡 ȿ ô
Ѵ. Ű ؼ activated charcoal 0.5~1.0g/kg 汸Ѵ.
Ǵ ý DZ (0.5mg/kg, IV) 10~20 ִ 4 Ѵ.
PB (3~15 mg/kg) õõ IVѴ. Ventricular tachycardiaÿ lidocaine CRI ϰ, propranolol 0.2~1.0 mg/kg, tid 汸 '50O)Ѵ.